Abstract
Objective The aim of this study was to investigate the prevalence of and potential risk factors associated with skin lesions resulting from the use of medical disinfectants and personal protective equipment (PPE) among epidemic prevention workers (including healthcare professionals, temporary sampling site workers, community members and volunteers) during the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic lockdown period in China.
Methods We conducted a survey to investigate the prevalence and factors associated with skin lesions during SARS-CoV-2 pandemic lockdown period among epidemic prevention workers in Gaojing town of Baoshan distract, Shanghai, China.
Results A total of 1033 questionnaires were reviewed, with 995 deemed valid. Among the 995 respondents, 209 (21.01%) reported comorbidities, while 786 (78.99%) were considered as controls. Autoimmune diseases, family history of dermatitis, cardiovascular diseases (CVDs), palmar and plantar hyperhidrosis, allergic diseases and the total time spent on skin cleansing and antisepsis procedures were identified as independent risk factors for these skin lesions.
Conclusion During the SARS-CoV-2 pandemic lockdown period, skin lesions among epidemic prevention workers was prevalent, which was primarily attributed to the use of medical disinfectants and PPE. These skin lesions frequently manifested as a combination of various subtypes across different areas of the body. Several individual factors, along with the total time spent on skin cleansing and skin antisepsis procedures, were identified as significant risk factors for the development of these skin lesions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Informed consent was obtained from all subjects involved in the study. This study was reviewed and approved by the Research Ethics Committee of Wusong Hospital, Zhongshan Hospital, Fudan University (IRB No.2022-SYY-15)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
Abbreviations
- SARS-CoV-2
- Severe Acute Respiratory Syndrome Coronavirus 2
- CVDs
- Cardiovascular diseases
- DRPIs
- Device-related pressure injuries
- MASD
- moisture-associated skin damage
- STs
- skin tears
- TNF
- tumor necrosis factor
- IL
- interleukin
- B
- coefficient of regression β (beta)
- SE
- standard error
- OR
- odds ratio
- 95% CI
- 95% confidence interval.
- PPE
- personal protective equipment
